Morgan Stanley downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Overweight to Equalweight.

For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.

Shares of Bristol-Myers Squibb Co. closed at $75.32 yesterday.